Outside Counsel Management at Pfizer

Pfizer develops a formalized budget for the matter as part of the early case assessment.  It is, as he says, a tangible way to frame the conversation with outside counsel.  And after many matters, Pfizer also does an after-action review to determine exactly what happened and how the process can be improved for the next time.

Transient

Winter 2006

Managing Litigation and Reducing Legal Costs as a Team Effort

Reprinted with permission of Inside Litigation magazine.

By A. Stickel

For Allen Waxman, who was recently named Senior Vice President & General Counsel at Pfizer Inc, lawsuits and the risk of litigation cannot drive business decisions. 

Under Waxman's leadership, Pfizer has also launched an early case assessment program.  When a matter comes in, the litigation practice group works to get a handle on what the strategy will be for that matter within 90 days. Pfizer also develops a formalized budget for the matter as part of the early case assessment. And after many matters, Pfizer also does an after-action review to determine exactly what happened and how the process can be improved for the next time.

Recently, the "Pfizer Partnering Program," or P3, was launched.  The litigation practice group initiated talks with law firms last year about the P3 program, and the first law firms were being selected as Inside Litigation went to press.

Argopoint Weighs In

Practice areas are the heart of any legal department and their performance determines if the department is successful. With the existence of numerous practice areas, it can be difficult to monitor their performance and spend while legal department leaders are under constant pressure to assure that they are functioning efficiently and at the lowest cost possible.

We assist practice leaders with identification and implementation of management best practices that enhance legal department performance

Argopoint routinely adapts and builds on successful best-practices to help clients reduce legal costs and improve the quality of legal services. The Pfizer litigation partnership is just one of numerous examples in the legal space in which innovative thinking has delivered high-impact results. A client-firm partnership program model is by no means the appropriate answer for all clients. However, our experience has shown that clients most open to new ideas have enjoyed the most significant reduction in cost and improvement quality of legal services.

Even in this changing legal environment, Argopoint's clients stay at the forefront of corporate innovation.   We founded Argopoint to meet this unfilled, but nonetheless real, need articulated by our core clients: providing top corporate legal departments with innovative management strategies to run large, challenging professional infrastructures that were under pressure to deliver results and increased economic efficiency. Our mission is to improve the effectiveness of even the most capable legal organizations.

Our clients depend on us to provide highly innovative, effective and industry-leading results. We combine evidence-based analytics with in-depth industry experience to deliver solutions that can be executed to achieve measurable, timely impact.  Though we pride ourselves on our proven quantitative and analytical techniques, we recognize that numbers and statistics never tell the whole story in the legal context. We perform a robust top-to-bottom assessment of every client’s specific situation and environment to reach a solution supported by facts, data and industry insight.

- -